Lamotrigine
Back to searchMolecule Structure
Scientific Name
Lamotrigine
Description of the Drug
Lamotrigine is a phenyltriazine antiepileptic used to treat some types of epilepsy and bipolar I disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00555
http://www.drugbank.ca/drugs/DB00555
Brand Name(s)
Lamictal, Lamictal cd, Lamictal odt, Lamictal xr, Lamotrigine
Company Owner(s)
Watson Laboratories Inc, Impax Laboratories Inc, Taro Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd, Atlantide Pharmaceuticals Ag, Sciegen Pharmaceuticals Inc, Lupin Ltd, Par Pharmaceutical Inc, Roxane Laboratories Inc, Zydus Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL35439 | ||
| PharmGKB | PA450164 | ||
| Human Metabolome Database | HMDB0014695 | ||
| WDI | LAMOTRIGI | ||
| DrugBank | DB00555 | ||
| PubChem: Thomson Pharma | 14823602 | ||
| PubChem | 3878 | ||
| Mcule | MCULE-7648410888 | ||
| LINCS | LSM-4104 | ||
| Nikkaji | J25.814H | ||
| BindingDB | 50031299 | ||
| EPA CompTox Dashboard | DTXSID2023195 | ||
| DrugCentral | 1540 | ||
| Brenda | 3705 | 7741 | 169768 |
| ChemicalBook | CB4166704 | ||
| Guide to Pharmacology | 2622 | ||
| GSRS | 35cdd74a-bc34-4bf9-bf0a-18f52136cd8f | ||
| rxnorm | LAMICTAL | LAMOTRIGINE | |
| PubChem: Drugs of the Future | 12013463 | ||
| ChEBI | 6367 | ||
| NIH Clinical Collection | SAM001246697 | ||
| ZINC | ZINC000000013156 |
